Hauck & Aufhaeuser set a €43.00 ($50.00) price target on Fielmann (FRA:FIE) in a research report report published on Monday, Borsen Zeitung reports. The brokerage currently has a sell rating on the stock.
Other equities analysts have also issued reports about the stock. HSBC set a €79.00 ($91.86) price objective on shares of Fielmann and gave the stock a buy rating in a report on Monday, November 11th. Kepler Capital Markets set a €60.50 ($70.35) target price on shares of Fielmann and gave the company a sell rating in a report on Tuesday, September 17th. Baader Bank set a €75.00 ($87.21) target price on Fielmann and gave the company a buy rating in a research report on Thursday, November 7th. Independent Research set a €76.00 ($88.37) price target on Fielmann and gave the stock a neutral rating in a research note on Friday, November 8th. Finally, Warburg Research set a €66.00 ($76.74) price target on Fielmann and gave the stock a neutral rating in a research report on Friday, November 8th. Two research analysts have rated the stock with a sell rating, four have assigned a hold rating and four have assigned a buy rating to the stock. The stock currently has a consensus rating of Hold and an average price target of €66.50 ($77.33).
Shares of FIE opened at €69.75 ($81.10) on Monday. The firm has a 50-day simple moving average of €70.55 and a two-hundred day simple moving average of €65.91. Fielmann has a 1-year low of €65.50 ($76.16) and a 1-year high of €77.50 ($90.12).
Fielmann Aktiengesellschaft invests in and operates optical and hearing aid businesses in Germany, Switzerland, Austria, and internationally. The company designs, manufactures, distributes, and retails visual aids and other optical products, including glasses, frames, lenses, sunglasses, contact lenses, and related articles and accessories, as well as hearing aids and accessories.
Read More: What is Net Asset Value (NAV)?
Receive News & Ratings for Fielmann Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fielmann and related companies with MarketBeat.com's FREE daily email newsletter.